Accelerate Diagnostics
AXDX
#9648
Rank
S$38.9 M
Marketcap
$1.55
Share price
-4.17%
Change (1 day)
-74.22%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.10 Billion

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are S$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$0.11 B-26.73%
2021-12-31S$0.15 B-22.74%
2020-12-31S$0.20 B8.12%
2019-12-31S$0.19 B9.42%
2018-12-31S$0.17 B1818.76%
2017-12-31S$9.1 M24.93%
2016-12-31S$7.28 M-18.29%
2015-12-31S$8.92 M77.18%
2014-12-31S$5.03 M107.6%
2013-12-31S$2.42 M
2012-07-31S$2.96 M69.96%
2011-07-31S$1.74 M-5.64%
2010-07-31S$1.84 M-3.88%
2009-07-31S$1.92 M-0.56%
2008-07-31S$1.93 M1.44%
2007-07-31S$1.9 M8.96%
2006-07-31S$1.75 M-21.37%
2005-07-31S$2.22 M30.56%
2004-07-31S$1.7 M-4.51%
2003-07-31S$1.78 M-20.91%
2002-07-31S$2.25 M11.57%
2001-07-31S$2.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$69.24 B 63,349.92%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.92 B 8,074.09%๐Ÿ‡บ๐Ÿ‡ธ USA
S$42.40 B 38,759.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.20 B 3,756.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.43 B 302.59%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.76 B 5,184.67%๐Ÿ‡บ๐Ÿ‡ธ USA